Journal of Acute Disease

REVIEW ARTICLE
Year
: 2017  |  Volume : 6  |  Issue : 6  |  Page : 241--244

Research progress of transfering mitochondria application in nanotubes in treatment of acute lung injury sepsis


Jin Qian1, Dong-Mei Sun1, Qi-Feng Huang1, Xiao-Ran Liu2 
1 Hainan Medical University, 3 Xueyuan Rd, Longhua District, Haikou City, Hainan Province, 570000, China
2 Hainan Medical University, 3 Xueyuan Rd, Longhua District, Haikou City, Hainan Province, 570000; Emergency Department, The First Affiliated Hospital of Hainan Medical University, Haikou, Hainan, 570100, China

Correspondence Address:
Xiao-Ran Liu
Emergency Department, The First Affiliated Hospital of Hainan Medical University, 31 Longhua Road, Haikou, Hainan
China

Acute lung injury (ALI) is a common complication of sepsis with characteristics of acute onset, rapid change in the disease and high mortality. Since current clinical treatment can only alleviate the unfavorable condition to a certain extent but cure, we urgently need to find an effective treatment. Most scholars believe that sepsis-induced ALI is associated with extensive mitochondrial damage. In recent years, a widely studied pluripotent stem cell that is mesenchymal stem cell has been proved to alleviate and treat sepsis-induced ALI by transporting mitochondria via nanotubes in a microtubule-dependent manner. Research progress in this field will be reviewed in this study.


How to cite this article:
Qian J, Sun DM, Huang QF, Liu XR. Research progress of transfering mitochondria application in nanotubes in treatment of acute lung injury sepsis.J Acute Dis 2017;6:241-244


How to cite this URL:
Qian J, Sun DM, Huang QF, Liu XR. Research progress of transfering mitochondria application in nanotubes in treatment of acute lung injury sepsis. J Acute Dis [serial online] 2017 [cited 2018 Jul 17 ];6:241-244
Available from: http://www.jadweb.org/article.asp?issn=2221-6189;year=2017;volume=6;issue=6;spage=241;epage=244;aulast=Qian;type=0